In our study, we observed the regulations of SETBP1 on the PI3K-AKT signaling pathway in MDS cells, and found that METTL14 activated the PI3K-AKT signaling pathway by upregulating SETBP1 expression. The gene discussed is METTL14; the disease is myelodysplastic syndrome.